96-9990. Availability of Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Protective Monoclonal Antibody Against Botulinum Neurotoxin Serotype F  

  • [Federal Register Volume 61, Number 80 (Wednesday, April 24, 1996)]
    [Notices]
    [Page 18124]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-9990]
    
    
    
    -----------------------------------------------------------------------
    
    
    DEPARTMENT OF DEFENSE
    
    Availability of Non-Exclusive, Exclusive, or Partially Exclusive 
    Licensing of U.S. Patent Application Concerning Protective Monoclonal 
    Antibody Against Botulinum Neurotoxin Serotype F
    
    AGENCY: U.S. Army Medical Research and Materiel Command, DOD.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
    availability of U.S. Patent Application SN 08/504,969, entitled 
    ``Protective Monoclonal Antibody Against Botulinum Neurotoxin Serotype 
    F,'' and filed July 20, 1995, for licensing. This patent has been 
    assigned to the United States Government as represented by the 
    Secretary of the Army.
    
    ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
    ATTN: Command Judge Advocate, Fort Detrick, Maryland 21702-5012.
    
    FOR FURTHER INFORMATION CONTACT:
    Mr. John F. Moran, Patent Attorney, 301-619-7807 or telefax 301-619-
    7714.
    
    SUPPLEMENTARY INFORMATION: This invention is related to the production 
    and use of novel neutralizing monoclonal antibodies against botulinum 
    neurotoxin serotype F (BNT/F) which are completely protective in vivo 
    against BNT/F, and hybridomas which produce monoclonal antibodies 
    against BNT/F. The invention is directed to the antibodies, to 
    processes of preparing the antibodies, to diagnostic, prophylactic, and 
    therapeutic methods and compositions employing the antibodies, and to 
    investigational, pharmaceutical, and other methods and compositions 
    employing the antibodies.
    Gregory D. Showalter,
    Army Federal Register Liaison Officer.
    [FR Doc. 96-9990 Filed 4-23-96; 8:45 am]
    BILLING CODE 3710-08-M
    
    

Document Information

Published:
04/24/1996
Department:
Defense Department
Entry Type:
Notice
Action:
Notice.
Document Number:
96-9990
Pages:
18124-18124 (1 pages)
PDF File:
96-9990.pdf